Search Results

95 Results for "bioadvance".

Sort By

Press Releases

Tolerance Bio, Inc. Launches With $17.2 Million in Seed Financing to Advance Thymus-Based Therapies for Immune-Mediated Diseases

October 16, 2024
·
6 min read
Pharm Country

BioAdvance Commits $4M To 14 Life Sciences Companies

August 14, 2017
·
3 min read
Deals

Renovacor Closes $11 Million Series A Financing to Advance First Gene Therapy for a Rare Cardiovascular Disease

Renovacor, Inc announced the successful completion of an $11 million Series A financing co-led by Novartis Venture Fund, Broadview Ventures, and BioAdvance, and joined by New Leaf Venture Partners and Innogest Capital.

August 14, 2019
·
6 min read
Pharm Country

BioAdvance Commits $3.2M to Life Sciences Companies in First Six Months of FY 2018

These investments represent a commitment of $3.2M to the success and growth of life science companies in the mid-Atlantic region.

January 16, 2018
·
4 min read
BioForest

KayoThera, Inc. Strengthens Financial Position with $5.2 Million in Grant and Expanded Series A Funding, Bringing Total Financial Support to $14 Million

KayoThera, Inc. announces the strengthening of its financial resources through multiple grant awards and expansion of its previously announced Series A financing.

July 19, 2023
·
7 min read
Business

BioAdvance Commits $2.9M To 15 Life Sciences Companies

July 27, 2016
·
4 min read
Pharm Country

BioAdvance Portfolio Companies Attract $85 Million Of Capital In 12 Months

June 11, 2015
·
3 min read
Pharm Country

BioAdvance Release: First Ever Life Sciences Ecosystem Interactive Map Launched In Pennsylvania

October 28, 2015
·
2 min read
Pharm Country

Vittoria Biotherapeutics Secures Over $15 Million in Private Financing Round to Support the Development of Novel CAR-T Cell Therapies

Vittoria Biotherapeutics announced it has secured over $15 million in a private financing round.

November 14, 2023
·
4 min read
Business

BioAdvance Expands Team to Support Portfolio Companies and New Investments

October 16, 2012
·
1 min read